Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 30, 2018 08:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference

RANCHO CORDOVA, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
August 29, 2018 08:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Poster Presentation at the 4th Annual CAR-TCR Summit

RANCHO CORDOVA, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
August 13, 2018 16:05 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update

RANCHO CORDOVA, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
August 06, 2018 08:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2018 and Host Conference Call on August 13

RANCHO CORDOVA, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care,...
July 16, 2018 08:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces the Launch of its PXP™ System for Automated Processing of Bone Marrow Cells

RANCHO CORDOVA, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous...
June 06, 2018 08:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Exhibition at The Orthobiologic Institute’s 9th Annual PRP & Regenerative Medicine Symposium

RANCHO CORDOVA, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous...
June 04, 2018 08:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Reduction in Operating Expenses

RANCHO CORDOVA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous...
May 23, 2018 08:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy

RANCHO CORDOVA, Calif., May 23, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous...
May 18, 2018 11:12 ET | Source: Cesca Therapeutics Inc.

Cesca Announces Closing of $5.5 Million Public Offering

RANCHO CORDOVA, Calif., May 18, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...
May 16, 2018 12:00 ET | Source: Cesca Therapeutics Inc.

Cesca Prices $5.5 Million Public Offering

RANCHO CORDOVA, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...